NCR Atleos Set To Join S&P SmallCap 600; To Replace iTeos Therapeutics Effective Prior To The Opening Of Trading On October 18
Portfolio Pulse from Benzinga Newsdesk
NCR Atleos is set to join the S&P SmallCap 600, replacing iTeos Therapeutics. The change will be effective prior to the opening of trading on October 18.
October 11, 2023 | 9:23 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
iTeos Therapeutics will be replaced by NCR Atleos in the S&P SmallCap 600 effective October 18.
Being removed from an index like the S&P SmallCap 600 can negatively impact a stock as it may lead to selling pressure from index funds that track the index. This could potentially lead to a short-term decrease in iTeos Therapeutics' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
NCR Atleos is set to join the S&P SmallCap 600, effective prior to the opening of trading on October 18.
Joining an index like the S&P SmallCap 600 can positively impact a stock as it may lead to buying pressure from index funds that track the index. This could potentially lead to a short-term increase in NCR Atleos' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100